{
    "2021-03-18": [
        [
            {
                "time": "",
                "original_text": "创纪录！人民金融·创新药指数涨2.88%！16个品种获批临床，贝达药业进军双抗，多款创新药取得重大进展",
                "features": {
                    "keywords": [
                        "创新药指数",
                        "涨2.88%",
                        "获批临床",
                        "贝达药业",
                        "双抗",
                        "重大进展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}